SEARCH HEALTH CONDITIONS BY ALPHABETS
Hyperphosphatemia of Renal Failure
Medications for Hyperphosphatemia of Renal Failure
Approximately Hyperphosphatemia of Renal Failure: Abnormally high concentration of phosphates in the circulating blood in patients with renal failure.
Drugs Used to Treat Hyperphosphatemia of Renal Failure
The following list of medications come found at the treating this particular condition, or somehow related to.
| Drug name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| Renvela | Rx | C | N | 6 reviews | 5.4 | ||
Generic name: sevelamer systemic Drug class: phosphate binders For users: dosage, interactions, side effects For professionals: Prescribing Information | |||||||
| Renagel | Rx | C | N | 1 inspection | 5.7 | ||
Generic name: sevelamer systemic Drug class: phosphate binders For users: dosage, interactions, side effects For professionals: Prescribing Information | |||||||
| sevelamer | Rx | C | N | 1 1 reviews | 5.8 | ||
Generic name: sevelamer systemic Brand titles: Renvela, Renagel Drug class: phosphate binders For users: dosage, interactions, For professionals: a Z Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
| Carafate | Rx | B | N | Add inspection | 0.0 | ||
Generic name: sucralfate systemic Drug class: miscellaneous GI brokers For users: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| Fosrenol | Rx | C | N | Two reviews | 5.5 | ||
Generic name: lanthanum carbonate systemic Drug class: phosphate binders For users: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| sucralfate | Rx | B | N | Add inspection | 0.0 | ||
Generic name: sucralfate systemic Brand name: Carafate Drug class: miscellaneous GI brokers For users: dosage, interactions, For professionals: a Z Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
| Velphoro | Rx | B | N | 6 reviews | 4.3 | ||
Generic name: sucroferric Oxy-hydroxide systemic Drug class: phosphate binders For users: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| Auryxia | Rx | B | N | 3 reviews | 7.0 | ||
Generic name: ferric citrate systemic Drug class: phosphate binders For users: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| lanthanum carbonate | Rx | C | N | 3 reviews | 5.7 | ||
Generic name: lanthanum carbonate systemic Brand name: Fosrenol Drug class: phosphate binders For users: dosage, interactions, For professionals: a Z Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
| ferric citrate | Rx | B | N | 3 reviews | 7.0 | ||
Generic name: ferric citrate systemic Brand name: Auryxia Drug class: phosphate binders For users: dosage, interactions, For professionals: a Z Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
| sucroferric Oxy-hydroxide | Rx | B | N | 6 reviews | 4.3 | ||
Generic name: sucroferric Oxy-hydroxide systemic Brand name: Velphoro Drug class: phosphate binders For users: interactions, For professionals: a Z Drug Truth, AHFS DI Monograph | |||||||
| magnesium carbonate | Rx/OTC | N | N | Add inspection | 0.0 | ||
Generic name: magnesium carbonate systemic Medicine class: minerals and electrolytes For users: dosage, interactions, For professionals: az Drug Truth | |||||||
Legend
| Rx | Prescription Only |
|---|---|
| OTC | On The Counter |
| Rx/OTC | Prescription or Over The Counter |
| Away Tag | This drug might well not be approved by the FDA for the treatment of this particular condition. |
| Pregnancy Category | |
|---|---|
| A | Adequate and well-controlled studies have failed to present a risk to the embryo in the first trimester of pregnancy (also there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in elderly women. |
| C | Animal research studies have demonstrated a negative effect in the fetus and there are no adequate and well-controlled studies in humans, but possible benefits may warrant used in pregnant women despite potential risks. |
| D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but possible benefits may warrant used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved with used in elderly women obviously outweigh potential rewards. |
| N | FDA have not classified this drug. |
| Controlled Substances Act (CSA) Program | |
|---|---|
| N | isn`t at the mercy of the Controlled Substances Act. |
| 1 | Has a higher potential for abuse. Has no accepted medical use in treatment in the United States. There is just a lack of accepted safety for use under medical supervision. |
| Two | Has a higher potential for abuse. Features a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may cause severe psychological or physical dependency. |
| 3 | includes a potential for abuse less than those in programs 1 and 2. Features a currently accepted medical use in treatment in the United States. Abuse may lead to physical dependence or high psychological dependence. |
| 4 | Has a very low potential for abuse relative to those in program 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in program 3. |
| 5 | Has a very low potential for abuse relative to those in program 4. Features a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in program 4. |
| Alcohol | |
|---|---|
| X | Interacts with Alcohol. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- R
- S
- T
- U
- V
- W
- X
- Y
- Z
Further information
Always seek advice from your healthcare provider to be sure the information displayed on these pages applies to some personal circumstances.
Top USA Pharma Companies
Popular Categories
Easily find an affordable health insurance plan
